Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1437-1446

  Gelman, Benjamin B ^a,b   Wolf, Dwayne A ^a   Rodriguez Wolf, Monica ^a   West, A Brian ^a   Haque, Abida K ^a   Cloyd, Miles ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN CORTEX; BRAIN INFECTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; NERVE DEGENERATION; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACETYLGALACTOSAMINE; BETA-GLUCOSIDASE; BRAIN; BRAIN DISEASES; CATHEPSINS; DNA, VIRAL; ENCEPHALITIS; HEXOSAMINIDASES; HIV INFECTIONS; HIV-1; HUMANS; HYDROLYSIS; LYSOSOMES; MALE; MONOCYTES; PHAGOCYTES; PROVIRUSES; TISSUE DISTRIBUTION;

EID: 0030715613     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (96)

1. Price RW, Sidtis JJ, Brew BJ: AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol 1991, 1:155-162
2. Brew BJ, Rosenblum M, Cronin K, Price RW: AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995, 38:563-570
3. Wiley CA, Achim C: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994, 36:673-767
4. Achim CL, Wang R, Miners DK, Wiley CA: Brain viral burden in HIV infection. J Neuropathol Exp Neurol 1994, 53:284-294
5. Wiley CA, Masliah E, Achim CL: Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol 1994, 4:315-325
6. Johnson RT, Glass JD, McArthur JC, Chesebro BW: Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency virus. Ann Neurol 1996, 39:392-395
7. Epstein LG, Gendelman HE: Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 1993, 33:429-436
8. Lipton SA, Gendelman HE: The dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995, 332:934-940
9. Glass JD, Fedor H, Wesselingh SL, McArthur JC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995, 38:755-762
10. Wesselingh SL, Power C, Glass J, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE: Intracerebral cytokine mRNA expression in AIDS dementia. Ann Neurol 1993, 33:576-582
11. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE: Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992, 31:349-360
12. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 1996, 334:1717-1725
13. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF: Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J Immunol 1991, 147:1522-1529
14. Heyes MP, Brew BB, Martin A, Price RW, Salazar A, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, Rubinow R, Markey SP: Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurologic status. Ann Neurol 1991, 29: 202-209
15. Lipton SA: Similarity of neuronal injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol 1996, 6:507-517
16. Petito CK, Roberts B: Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995, 146:1121-1130
17. Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle-Biassette H, Wingertsmann L, Durigon M, Hurtrel B, Chiodi F, Bell J, Lantos P: Neuropathology of early HIV-1 infection. Brain Pathol 1996, 6:1-15
18. Sharer LR, Krajewskj S, James H, Epstein LG, Reed JC, Gelbard HA: Apoptosis related gene products in brains of pediatric patients with HIV encephalitis. J Neuropathol Exp Neurol 1996, 55:663
19. Olano JP, Wolf DA, Keherly M, Gelman BB: Quantifying apoptosis in banked human brains using flow cytometry. J Neuropathol Exp Neurol 1996, 55:1164-1172
20. Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HS, Epstein L, Gelbard H, Flanagan E, Reinhard J, Pirruccello SJ, Gendelman HE: Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol 1996, 149:1027-1053
21. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL: Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med 1996, 2:417-428
22. Müller F: Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Rad Biol Med 1992, 13:651-657
23. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TW, Dawson VL: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921
24. Bukrinsky M, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullin ME, Lipton SA, Gendelman HE: Regulation of nitric oxide synthetase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995, 181:735-745
25. Giulian D, Wendt E, Vaca K, Noonan CA: The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 1993, 90:2769-2773
26. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268:429-431
27. Nottet HSLM, Jett M, Flanagan CR, Zhai Q-H, Persidsky Y, Rizzino A, Bernton EW, Genis P, Baldwin T, Schwartz J, LaBenz CJ, Gendelman HE: A regulatory role for astrocytes in HIV-1 encephalitis: Overexpression of eicosanoids, platelet activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995, 154:3567-3581
28. Schnyder J, Baggiolini M: Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages. J Exp Med 1978, 148:435-450
29. Adams DO: Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J Immunol 1980, 124:286-292
30. Altieri DC: Proteases and protease receptors in modulation of leukocyte effector functions. J Leukocyte Biol 1995, 58:120-127
31. Watanabe N, Niitsu Y, Neda H, Sone H, Yamauchi N, Maeda M, Urushizaki I: Cytocidal mechanism of TNF: effects of lysosomal enzyme and hydroxyl radical inhibitors on cytotoxicity. Immunopharm Immunotoxicol 1988, 10:109-116
32. Ferrante A: Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 1989, 57:2115-2122
33. Liddil JD, Dorr RT, Scuderi P: Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells. Cancer Res 1989, 49:2722-2728
34. Sappino AP, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, Vassalli JD: Extracellular proteolysis in the adult murine brain. J Clin Invest 1993, 92:679-685
35. Vey E, Burger D, Dayer JM: Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon indirect contact with stimulated T cells. Eur J Immunol 1996, 26:2404-2409
36. Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM: A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 1995, 155:5198-5205
37. Laouar A, Villiers C, Sanceau J, Maison C, Colomb M, Wietzerbin J, Bauvois B: Inactivation of interleukin-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities. Eur J Biochem 1993, 215:825-831
38. Morgan BP: Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci 1995, 32:265-298
39. Marks N, Berg N, Benuck M: Preferential action of rat brain cathepsin as a peptidyl dipeptidase converting pro-opioid oligopeptides. Arch Biochem Biophys 1986, 249:489-499
40. Mentlein R, Dahms P: Endopeptidases 24. 16 and 24. 15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J Neurochem 1994, 62:27-36
41. Dahms P, Mentlein R: Purification of the main somatostatin-degrading proteases form rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24. 15 and 24. 16. Eur J Biochem 1992, 208:145-154
42. Miyazawa K, Shimomura T, Kitamura N: Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 1996, 271:3615-3618
43. Banik NL: Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolylic enzymes. Crit Rev Neurobiol 1992, 16: 257-271
44. Cammer W, Bloom BR, Norton WT, Gordon S: Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci USA 1978, 75:1554-1558
45. Berlet HH, Ilzenhöfer H: Elucidation of cathepsin B-like activity associated with extracts of human myelin basic protein. FEBS Lett 1985, 179:299-302
46. Benuck S, Marks N, Hashim G: Metabolic instability of myelin proteins: breakdown of basic protein induced by brain cathepsin D. Eur J Biochem 1975, 52:615-621
47. Marks N, Grynbaum A, Benuck M: On the sequential cleavage of myelin basic protein by cathepsin A and D. J Neurochem 1976, 27:765-768
48. Nakajima K, Tsuzaki N, Shimojo M, Hamanoue M, Kohsaka S: Microglia isolated from rat brain secrete a urokinase-type plasminogen activator. Brain Res 1992, 577:285-292
49. Smirnova IV, Ho GJ, Fenton JW II, Festoff BW: Extracellular proteolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemostasis 1994, 20:426-432
50. Liu Y, Fields RD, Festoff BW, Nelson PG: Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc Natl Acad Sci USA 1994, 91:10300-10304
51. Seeds NW, Williams BL, Bickford PC: Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 1995, 270:1992-1994
52. Hausinger A, Volknandt W, Zimmerman H: Calcium-dependent endogenous proteolysis of the vesicle proteins synaptobrevin and synaptotagmin. NeuroReport 1995, 6:637-641
53. Liu Y, Fields RD, Fitzgerald S, Festoff BW, Nelson PG: Proteolytic activity, synapse elimination, and the Hebb synapse. J Neurobiol 1994, 25:325-335
54. Chang J, Wigley F, Newcombe D: Neutral protease activation of peritoneal macrophage prostaglandin synthesis. Proc Natl Acad Sci USA 1980, 77:4736-4740
55. King RW, Deshaies RJ, Peters J-M, Kischner MW: How proteolysis drives the cell cycle. Science 1996, 274:1652-1659
56. Williams MS, Henkart PA: Apoptotic cell death induced by intracellular proteolysis. J Immunol 1994, 153:4247-4255
57. Liu C-C, Young LHY, Young JD-E: Lymphocyte-mediated cytolysis and disease. N Engl J Med 1996, 335:1651-1659
58. Marthinuss J, Andrade-Gordon P, Seiberg M: A secreted serine protease can induce apoptosis in Pam212 keratinocytes. Cell Growth Differ 1995, 6:807-816
59. Smyth MJ, Trapani JA: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995, 16:202-206
60. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 1995, 267:2000-2003
61. Haque AK, Cowan WT, Smith JH: The decedent affairs office: a unique centralized service. J Am Med Assoc 1991, 266:1397-1399
62. Gelman BB, Papa L, Davis MH, Gruenstein E: Decreased lysosomal dipeptidyl aminopeptidase-I activity in cultured human skin fibroblasts in Duchenne's muscular dystrophy. J Clin Invest 1980, 65: 1298-1406
63. Gelman BB, Dholakia S, Casper K, Kent TA, Cloyd MW, Freeman D Jr: Expansion of the cerebral ventricles and correlation with acquired immunodeficiency syndrome neuropathology in 232 patients. Arch Pathol Lab Med 1996, 120:866-871
64. Abu-Alfa AK, Kuan S-F, West AB, Reyes-Múgica M: Cathepsin D in intestinal ganglion cells. Am J Surg Pathol 1997, 21:201-205
65. Gelman BB, Rodriguez-Wolf MG, Wen J, Kumar S, Campbell GA, Herzog N: Siderotic cerebral macrophages in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1992, 116:509-516
66. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D: HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991, 1:143-152
67. Snedicor GW, Cochran WG: Statistical Methods, ed. Ames. IA, The Iowa State University Press, 1980, pp 565-575
68. Bernstein H-G, Wiederanders B, Rinne A, Dorn A: Distribution of cathepsin D immunoreactivity in the central nervous system of rat and selected brain regions of man. Acta Histochem 1985, 77:139-142
69. Wiley CA, Schrier RD, Nelson JA, Lamped PW, Oldstone MBA: Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 1986, 83:7089-7093
70. Gelman BB: Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol 1993, 34: 65-70
71. Wiley CA: Polymerase chain reaction in situ hybridization: opening Pandora's box? Ann Neurol 1996, 39:691-692
72. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD: Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996, 39:705-711
73. Sinclair E, Gray F, Ciarde A, Scaravilli F: Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 1994, 53: 43-50
74. Wiestler OD, Leib SL, Brustle O, Spiegel H, Kleihues P: Neuropathology and pathogenesis of HIV encephalopathies. Acta Histochem Suppl 1992, 42:107-114
75. Boni J, Emmerich BS, Leib SL, Wiestler OD, Schupbach J, Kleiheus P: PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993, 43:1813-1817
76. Petite CK: Neuropathology of acquired immunodeficiency syndrome. Principles and Practice of Neuropathology. Edited by Nelson JS, Parisi JE, Schochet SS Jr. St. Louis, MO, Mosby, 1993, pp 88-108
77. Neurath H, Walsh KA: Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci USA 1976, 73:3825-3832
78. Schmidbauer M, Huemer M, Cristina S, Trabattoni GR, Budka H: Morphologic spectrum, distribution and clinical correlation of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol 1992, 18:489-501
79. Cohen SR, Herndon RM, McKhann GM: Radioimmunoassay of myelin basic protein in spinal fluid: an index of active demyelination. N Engl J Med 1976, 295:1455-1457
80. Halonen T, Kilpelainen H, Pitkanen A, Riekkinen PJ: Lysosomal hydrolases in cerebrospinal fluid in multiple sclerosis patients: a follow-up study. J Neurol Sci 1987, 79:267-274
81. Liuzzi GM, Mastroianni, Fanelli M, Massetti AP, Vullo V, Delia S, Riccio P: Myelin degrading activity in the CSF of HIV-1-infected patients with neurologic diseases. NeuroReport 1994, 6:157-160
82. Cammer W, Brosnan CF, Basile C, Bloom BR, Norton WT: Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination. Brain Res 1986, 364:91-101
83. Banati RB, Rothe G, Valet G, Kreutzberg GW: Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. Glia 1993, 7:183-191
84. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA: Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992, 66:285-291
85. i from class II MHC α-and β-chains. J Immunol 1991, 146:3877-3880
86. Roche PA, Cresswell P: Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 1991, 88:3150-3154
87. Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V: Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med 1996, 183:1331-1338
88. Morton PA, Zacheis ML, Giacoletto KS, Manning JA, Schwartz BD: Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J Immunol 1995, 154:137-150
89. Dickson DE, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF: Microglia in human disease, with an emphasis on acquired immunodeficiency syndrome. Lab Invest 1991, 64:135-156
90. Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH, Green DR: The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/ CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J 1996, 15:2407-2416
91. Quan LT, Tewari M, O'Rourke K, Dixit V, Snipas SJ, Poirier GG, Ray C, Pickup DJ, Salvesen GS: Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci USA 1996, 93:1972-1976
92. Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He WW, Dixit VM: ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 1996, 271:16720-16724
93. Darmon AJ, Nicholson DW, Bleackley RC: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995, 377:446-448
94. Deiss LP, Galilnka H, Berissi H, Cohen O, Kimchi A: Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996, 15:3861-3870
95. Deeks SG, Smith M, Holodniy M, Kahn JO: HIV-1 protease inhibitors: a review for clinicians. J Am Med Assoc 1997, 277:145-153
96. Boehme DH, Umezawa H, Hashim G, Marks N: Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin). Neurochem Res 1978, 3:185-194